Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus rIFN-gamma versus ISCADOR M versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis

UR Kleeberg, S Suciu, EB Brocker, DJ Ruiter, C Chartier, D Lienard, J Marsden, D Schadendorf, Lex Eggermont

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)390-402
Number of pages13
JournalEuropean Journal of Cancer
Volume40
Issue number3
Publication statusPublished - 2004

Cite this